Literature DB >> 18308785

Review: Bupropion and SSRI-induced side effects.

K Demyttenaere1, L Jaspers.   

Abstract

Selective serotonin reuptake inhibitors (SSRIs) are a first line treatment option for millions of patients, due to the positive balance between efficacy and tolerability. However, some side effects associated with their use, can impair quality of life and compliance with treatment. This paper reviews the prevalence of sexual dysfunction, weight gain and emotional detachment during SSRI treatment, the profile of bupropion for each of these events and the ability of bupropion to reverse them. Double-blind trials, open-label trials and anecdotical reports derived from Medline were included. First, there is robust evidence that SSRIs can induce sexual side effects and that bupropion causes less sexual dysfunction than SSRIs. There is limited, mainly open-label evidence that bupropion can reverse SSRI-induced sexual side effects. Second, there is good evidence that long-term treatment with some SSRIs can result in weight gain and that long-term treatment with bupropion can result in a small weight loss. There is only anecdotical evidence that bupropion can reverse SSRI-induced weight gain. Third, treatment with SSRIs has been associated with ;emotional detachment', although controversy exists about this concept. No data are available on the profile of bupropion for ;emotional detachment' or for the reversal of SSRI-induced ;emotional detachment' by bupropion-addition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18308785     DOI: 10.1177/0269881107083798

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  40 in total

Review 1.  The efficacy and tolerability of bupropion in the treatment of major depressive disorder.

Authors:  Ricardo Moreira
Journal:  Clin Drug Investig       Date:  2011-10-19       Impact factor: 2.859

2.  Investigation of antidepressant medication usage after bariatric surgery.

Authors:  Julie L Cunningham; Cory C Merrell; Michael Sarr; Kristin J Somers; Donald McAlpine; Michael Reese; Susanna R Stevens; Matthew M Clark
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

Review 3.  Impact of Antidepressant Drugs on Sexual Function and Satisfaction.

Authors:  David S Baldwin; Chris Manson; Magda Nowak
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

Review 4.  A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2010-04-29       Impact factor: 7.616

5.  Psychotropic medication use mediates the relationship between mood and anxiety disorders and obesity: findings from a nationally representative sample.

Authors:  Jasper A J Smits; David Rosenfield; Amber A Mather; Candyce D Tart; Christine Henriksen; Jitender Sareen
Journal:  J Psychiatr Res       Date:  2010-11       Impact factor: 4.791

Review 6.  The role of dopaminergic agents in improving quality of life in major depressive disorder.

Authors:  Waguih William IsHak; Michael Davis; Jessica Jeffrey; Konstantin Balayan; Robert N Pechnick; Kara Bagot; Mark Hyman Rapaport
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 7.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

8.  Resolution of pregabalin and mirtazapine associated restless legs syndrome by bupropion in a patient with major depressive disorder.

Authors:  Young-Min Park; Heon-Jeong Lee; Seung-Gul Kang; Jae-Hyuck Cho; Leen Kim
Journal:  Psychiatry Investig       Date:  2009-11-19       Impact factor: 2.505

9.  Antidepressant use before and after the diagnosis of type 2 diabetes: a longitudinal modeling study.

Authors:  Mika Kivimäki; Adam G Tabák; Debbie A Lawlor; G David Batty; Archana Singh-Manoux; Markus Jokela; Marianna Virtanen; Paula Salo; Tuula Oksanen; Jaana Pentti; Daniel R Witte; Jussi Vahtera
Journal:  Diabetes Care       Date:  2010-04-05       Impact factor: 17.152

10.  Common mental disorder and obesity: insight from four repeat measures over 19 years: prospective Whitehall II cohort study.

Authors:  Mika Kivimäki; Debbie A Lawlor; Archana Singh-Manoux; G David Batty; Jane E Ferrie; Martin J Shipley; Hermann Nabi; Séverine Sabia; Michael G Marmot; Markus Jokela
Journal:  BMJ       Date:  2009-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.